US Stock MarketDetailed Quotes

Keros Therapeutics (KROS)

Watchlist
  • 11.510
  • -0.050-0.43%
Close Apr 24 16:00 ET
  • 11.550
  • +0.040+0.35%
Post 16:35 ET
227.76MMarket Cap5.00P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Keros Therapeutics (KROS) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
6,774.96%244.06M
-87.34%385K
3,575.77%14.26M
49,002.70%18.17M
254,413.25%211.25M
2,250.99%3.55M
2,027.27%3.04M
4,750.00%388K
37K
83K
Operating revenue
6,774.96%244.06M
-87.34%385K
3,575.77%14.26M
49,002.70%18.17M
254,413.25%211.25M
2,250.99%3.55M
2,027.27%3.04M
4,750.00%388K
--37K
--83K
Cost of revenue
Gross profit
Operating expense
-17.20%176.49M
-46.14%29.66M
-49.79%29.65M
14.88%57.99M
21.91%59.21M
27.11%213.15M
24.57%55.06M
36.40%59.05M
22.11%50.48M
24.95%48.57M
Selling and administrative expenses
14.96%46.85M
10.11%11.74M
3.13%10.13M
45.39%14.48M
1.83%10.5M
16.99%40.75M
17.13%10.67M
7.35%9.82M
13.15%9.96M
32.53%10.31M
-General and administrative expense
14.96%46.85M
10.11%11.74M
3.13%10.13M
45.39%14.48M
1.83%10.5M
16.99%40.75M
17.13%10.67M
7.35%9.82M
13.15%9.96M
32.53%10.31M
Research and development costs
-25.33%129.64M
-60.75%17.91M
-60.35%19.52M
7.38%43.5M
27.32%48.71M
28.37%173.63M
21.71%45.63M
44.19%49.23M
24.53%40.52M
23.05%38.26M
Other operating expenses
----
----
----
----
----
48.42%-1.24M
----
----
----
----
Operating profit
132.24%67.57M
43.73%-29.27M
73.77%-15.38M
21.06%-39.82M
413.59%152.04M
-25.10%-209.6M
-18.07%-52.02M
-35.53%-58.66M
-22.02%-50.44M
-24.73%-48.48M
Net non-operating interest income expense
0
Non-operating interest expense
----
----
----
----
----
--0
----
----
----
----
Other net income (expense)
7.92%24.33M
-31.72%4.3M
17.17%6.68M
33.13%6.9M
20.21%6.45M
54.94%22.54M
65.01%6.29M
48.46%5.7M
35.23%5.18M
75.17%5.37M
Gain on sale of security
5.84%24.87M
-38.30%4.02M
19.68%6.93M
32.39%7.12M
16.98%6.79M
59.24%23.5M
73.56%6.52M
48.27%5.79M
34.89%5.38M
86.99%5.81M
Other non- operating income (expenses)
43.50%-539K
219.21%273K
-175.00%-253K
-12.76%-221K
22.65%-338K
-363.11%-954K
-508.93%-229K
-37.31%-92K
-26.45%-196K
-992.50%-437K
Income before tax
149.13%91.9M
45.38%-24.98M
83.56%-8.7M
27.26%-32.92M
467.62%158.49M
-22.26%-187.05M
-13.62%-45.73M
-34.27%-52.96M
-20.67%-45.26M
-20.42%-43.11M
Income tax
1,527.67%4.88M
-604.67%-1.51M
-1.42M
-2.22M
10.04M
300K
300K
0
0
0
Net income
146.44%87.01M
49.03%-23.46M
86.25%-7.28M
32.17%-30.7M
444.32%148.45M
-22.46%-187.35M
-14.37%-46.03M
-34.27%-52.96M
-20.67%-45.26M
-20.42%-43.11M
Net income continuous Operations
146.44%87.01M
49.03%-23.46M
86.25%-7.28M
32.17%-30.7M
444.32%148.45M
-22.46%-187.35M
-14.37%-46.03M
-34.27%-52.96M
-20.67%-45.26M
-20.42%-43.11M
Minority interest income
Net income attributable to the parent company
146.44%87.01M
49.03%-23.46M
86.25%-7.28M
32.17%-30.7M
444.32%148.45M
-22.46%-187.35M
-14.37%-46.03M
-34.27%-52.96M
-20.67%-45.26M
-20.42%-43.11M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
146.44%87.01M
49.03%-23.46M
86.25%-7.28M
32.17%-30.7M
444.32%148.45M
-22.46%-187.35M
-14.37%-46.03M
-34.27%-52.96M
-20.67%-45.26M
-20.42%-43.11M
Basic earnings per share
146.80%2.34
24.56%-0.86
87.23%-0.18
39.20%-0.76
402.48%3.66
3.85%-5
14.93%-1.14
-6.02%-1.41
1.57%-1.25
3.97%-1.21
Diluted earnings per share
146.00%2.3
24.56%-0.86
87.23%-0.18
39.20%-0.76
399.17%3.62
3.85%-5
14.93%-1.14
-6.02%-1.41
1.57%-1.25
3.97%-1.21
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 6,774.96%244.06M-87.34%385K3,575.77%14.26M49,002.70%18.17M254,413.25%211.25M2,250.99%3.55M2,027.27%3.04M4,750.00%388K37K83K
Operating revenue 6,774.96%244.06M-87.34%385K3,575.77%14.26M49,002.70%18.17M254,413.25%211.25M2,250.99%3.55M2,027.27%3.04M4,750.00%388K--37K--83K
Cost of revenue
Gross profit
Operating expense -17.20%176.49M-46.14%29.66M-49.79%29.65M14.88%57.99M21.91%59.21M27.11%213.15M24.57%55.06M36.40%59.05M22.11%50.48M24.95%48.57M
Selling and administrative expenses 14.96%46.85M10.11%11.74M3.13%10.13M45.39%14.48M1.83%10.5M16.99%40.75M17.13%10.67M7.35%9.82M13.15%9.96M32.53%10.31M
-General and administrative expense 14.96%46.85M10.11%11.74M3.13%10.13M45.39%14.48M1.83%10.5M16.99%40.75M17.13%10.67M7.35%9.82M13.15%9.96M32.53%10.31M
Research and development costs -25.33%129.64M-60.75%17.91M-60.35%19.52M7.38%43.5M27.32%48.71M28.37%173.63M21.71%45.63M44.19%49.23M24.53%40.52M23.05%38.26M
Other operating expenses --------------------48.42%-1.24M----------------
Operating profit 132.24%67.57M43.73%-29.27M73.77%-15.38M21.06%-39.82M413.59%152.04M-25.10%-209.6M-18.07%-52.02M-35.53%-58.66M-22.02%-50.44M-24.73%-48.48M
Net non-operating interest income expense 0
Non-operating interest expense ----------------------0----------------
Other net income (expense) 7.92%24.33M-31.72%4.3M17.17%6.68M33.13%6.9M20.21%6.45M54.94%22.54M65.01%6.29M48.46%5.7M35.23%5.18M75.17%5.37M
Gain on sale of security 5.84%24.87M-38.30%4.02M19.68%6.93M32.39%7.12M16.98%6.79M59.24%23.5M73.56%6.52M48.27%5.79M34.89%5.38M86.99%5.81M
Other non- operating income (expenses) 43.50%-539K219.21%273K-175.00%-253K-12.76%-221K22.65%-338K-363.11%-954K-508.93%-229K-37.31%-92K-26.45%-196K-992.50%-437K
Income before tax 149.13%91.9M45.38%-24.98M83.56%-8.7M27.26%-32.92M467.62%158.49M-22.26%-187.05M-13.62%-45.73M-34.27%-52.96M-20.67%-45.26M-20.42%-43.11M
Income tax 1,527.67%4.88M-604.67%-1.51M-1.42M-2.22M10.04M300K300K000
Net income 146.44%87.01M49.03%-23.46M86.25%-7.28M32.17%-30.7M444.32%148.45M-22.46%-187.35M-14.37%-46.03M-34.27%-52.96M-20.67%-45.26M-20.42%-43.11M
Net income continuous Operations 146.44%87.01M49.03%-23.46M86.25%-7.28M32.17%-30.7M444.32%148.45M-22.46%-187.35M-14.37%-46.03M-34.27%-52.96M-20.67%-45.26M-20.42%-43.11M
Minority interest income
Net income attributable to the parent company 146.44%87.01M49.03%-23.46M86.25%-7.28M32.17%-30.7M444.32%148.45M-22.46%-187.35M-14.37%-46.03M-34.27%-52.96M-20.67%-45.26M-20.42%-43.11M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 146.44%87.01M49.03%-23.46M86.25%-7.28M32.17%-30.7M444.32%148.45M-22.46%-187.35M-14.37%-46.03M-34.27%-52.96M-20.67%-45.26M-20.42%-43.11M
Basic earnings per share 146.80%2.3424.56%-0.8687.23%-0.1839.20%-0.76402.48%3.663.85%-514.93%-1.14-6.02%-1.411.57%-1.253.97%-1.21
Diluted earnings per share 146.00%2.324.56%-0.8687.23%-0.1839.20%-0.76399.17%3.623.85%-514.93%-1.14-6.02%-1.411.57%-1.253.97%-1.21
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +16.17%
Sample Name
Sample Code
 +12.91%
Sample Name
Sample Code
 +12.09%
4
VanEck Oil Services ETF
OIH
+5.81%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.90%
Sample Name
Sample Code
 +11.93%
Sample Name
Sample Code
 +8.63%
4
United Microelectronics
UMC
+5.32%
5
Chagee Holdings
CHA
+3.37%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -